Literature DB >> 22044434

Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.

Paramananthan Mariappan1, Steven M Finney, Elizabeth Head, Bhaskar K Somani, Alexandra Zachou, Gordon Smith, Said F Mishriki, James N'Dow, Kenneth M Grigor.   

Abstract

UNLABELLED: Study Type - Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence of cis, early recurrence following white light TURBT for new bladder tumours is also determined by surgeon experience, completeness of resection and presence or absence of detrusor muscle in the specimen. This study aims to validate surgeon experience and detrusor muscle as independent predictors of early recurrence following apparently complete white light TURBT in new bladder tumours.
OBJECTIVE: To validate in patients undergoing first transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), the presence/absence of detrusor muscle (DM) in the specimen and surgeon experience as independent predictors of the quality of TURBT. PATIENTS AND METHODS: Patients with new NMIBC, who had undergone complete first resections were recruited from a prospectively maintained cohort from the 1980s at the Western General Hospital, Edinburgh, UK and a contemporary cohort from the Aberdeen Royal Infirmary, UK.   Tumour size, multiplicity, surgeon category, presence or absence of DM in the specimen, grade, stage, findings at first check cystoscopy and early re-TURBT were evaluated. Surgeons were stratified into a senior group (consultant and trainees in year five or six) and a junior group (trainees below year five). Early recurrence, or recurrence rate at the first follow up cystoscopy (RRFFC), was used to measure quality and was defined as finding pathologically confirmed tumour at early re-TURBT or the first check cystoscopy.
RESULTS: From a total of 566 patients evaluated from both cohorts, 473 NMIBC specimens were suitable for analysis. Logistic regression multivariate analysis revealed that the absence of DM was associated with a higher RRFFC (odds ratio [OR]= 3.6, 95% CI = 1.7-7.5, P < 0.001). Senior surgeons were more likely to resect DM (OR = 4.9, 95% CI = 2.3-10.7, P < 0.001) Senior surgeons were independently associated with a lower RRFFC (OR = 5.3, 95% CI = 2.1-12.9, P < 0.001).
CONCLUSIONS: Detrusor muscle status at the first, apparently complete, TURBT and surgeon's experience independently predict the quality of TURBT. •  Documented complete resection by experienced surgeons with DM presence (good quality white-light TURBT) should be considered a benchmark for white-light TURBT in NMIBC.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 22044434     DOI: 10.1111/j.1464-410X.2011.10571.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  25 in total

Review 1.  Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer.

Authors:  Ashish M Kamat; J Alfred Witjes; Maurizio Brausi; Mark Soloway; Donald Lamm; Raj Persad; Roger Buckley; Andreas Böhle; Marc Colombel; Joan Palou
Journal:  J Urol       Date:  2014-03-25       Impact factor: 7.450

2.  The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

Authors:  Stefania Zamboni; Marco Moschini; Andrea Gallina; Renzo Colombo; Francesco Montorsi; Alberto Briganti; Andrea Salonia; Alessandro Antonelli; Claudio Simeone; Sandra Belotti; Luca Cristinelli; Agostino Mattei; Philipp Baumeister
Journal:  World J Urol       Date:  2019-03-25       Impact factor: 4.226

Review 3.  A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors.

Authors:  Yasser Osman; Ahmed M Harraz
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 4.  Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited.

Authors:  Matthew J Pagano; Gina Badalato; James M McKiernan
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

5.  The Diagnosis and Treatment of Patients With Bladder Carcinoma.

Authors:  Maike de Wit; Margitta M Retz; Claus Rödel; Jürgen E Gschwend
Journal:  Dtsch Arztebl Int       Date:  2020-04-15       Impact factor: 5.594

6.  When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center.

Authors:  Deepak Prakash Bhirud; Ankur Mittal; Sunil Kumar; Tushar Aditya Narain; Sanjeev Kishore; Shiv Charan Navriya; Satish Kumar Ranjan; Vikas Kumar Panwar
Journal:  Indian J Surg Oncol       Date:  2022-03-18

Review 7.  High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.

Authors:  Oscar Rodriguez Faba; Joan Palou; Alberto Breda; H Villavicencio
Journal:  World J Urol       Date:  2012-10-16       Impact factor: 4.226

8.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 9.  The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.

Authors:  Ilhan Karaoglu; Antoine G van der Heijden; J Alfred Witjes
Journal:  World J Urol       Date:  2013-10-29       Impact factor: 4.226

10.  A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.

Authors:  Christopher Anderson; Ryan Weber; Darshan Patel; William Lowrance; Adam Mellis; Michael Cookson; Maximilian Lang; Daniel Barocas; Sam Chang; Elizabeth Newberger; Jeffrey S Montgomery; Alon Z Weizer; Cheryl T Lee; Bruce R Kava; Max Jackson; Anoop Meraney; Daniel Sjoberg; Bernard Bochner; Guido Dalbagni; Machele Donat; Harry Herr
Journal:  J Urol       Date:  2016-04-01       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.